ArticlePLoS computational biology2026
Mobility data resolution needed to inform predictive models of spatial epidemic spread from mobile phone data.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterizing the impact of incorporating spatially aggregated human mobility data into infectious disease models.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human mobility fundamentally shapes the spatial spread of infectious diseases, yet the level of detail required from mobility data to accurately inform epidemic models remains unclear. Mobile phone records offer unprecedented resolution on population movements, but little attention has been devoted however to determining (i) which aspects of mobility are epidemiologically relevant and (ii) what level of data resolution is necessary to capture spatial invasion dynamics. Using mobile phone records from 9.5 million users in Senegal (approximately 80% of the population), we systematically compare three approaches to aggregating mobility data for epidemic modeling. These approaches span a range of resolutions: high-resolution tracking of all individual displacements between consecutive visited locations (HR), medium-resolution accounting for time spent in all visited locations (MR), and low-resolution identification of the most-visited location (LR). We incorporate these mobility representations into a metapopulation epidemic model that explicitly accounts for transmission from residents, visitors, and returning travelers, and simulate diseases with varying transmissibility corresponding to controlled epidemic conditions, seasonal influenza-like transmission, and highly transmissible pathogens. We find that preserving all observed displacements in individual trajectories does not necessarily improve the epidemiological relevance of mobility in pathogens spatial transmission. Instead, displacement-based networks fragment long-range trips and underestimate key spatial connections relevant for disease spread. In contrast, approaches that capture where individuals spend most of their time (such as home, work, or school) more accurately reproduce spatial invasion patterns. Accounting for additional daily activities beyond these primary locations provides little additional epidemiological information. Our results suggest that lower-resolution mobility indicators capturing time spent at key locations are sufficient to inform predictive epidemic models. These findings have important implications for both epidemic modeling and data governance, indicating that mobile phone data can be aggregated to reduce privacy issues while still providing the essential information needed to model spatial disease transmission.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.